{"id":452089,"date":"2021-03-05T18:33:08","date_gmt":"2021-03-05T23:33:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=452089"},"modified":"2021-03-05T18:33:08","modified_gmt":"2021-03-05T23:33:08","slug":"cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/","title":{"rendered":"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">VANCOUVER, Washington, March  05, 2021  (GLOBE NEWSWIRE) &#8212; <strong>CytoDyn Inc. (OTC.QB: CYDY)<\/strong>, (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman and Chief Medical Officer, Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer and Harish Seethamraju, M.D., Medical Director for the Mount Sinai Lung Transplantation Program, will host an investment community webcast on Monday, March 8, 2021.<\/p>\n<p>Management will discuss the data from the recently completed Phase 3 trial for severe-to-critically ill COVID-19 patients, the regulatory path forward with several countries, as well as updates on other clinical and corporate priorities.<\/p>\n<p>Management will provide approximately 90 minutes to address questions submitted online by analysts and investors.<\/p>\n<p>\n        <strong>Date: <\/strong> Monday, March 8, 2021<br \/><strong>Time:<\/strong> 1:00 pm PT \/ 4:00 pm ET<br \/><strong>Dial-In:<\/strong> None.<br \/><strong>Questions: <\/strong><\/p>\n<ul type=\"disc\">\n<li>Prior to the webcast, questions can be submitted online to <a href=\"mailto:CYDY_Team@cytodyn.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">CYDY_Team@cytodyn.com<\/a><\/li>\n<li>During the webcast, questions can be submitted through the webcast link below.<\/li>\n<\/ul>\n<p>This is a \u201clisten only\u201d webcast, which can be accessed via CytoDyn\u2019s corporate website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=w0bxaUcFTAeb2zvLK1EnwNWgYh_EUd7SnxA7qyFlfVYAvvd98yOp5yjsFp5a2etr_WldMWekFKKYaWtHOu8sng==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.cytodyn.com<\/a>\u00a0under the Investors section\/IR Calendar and will be archived for 30 days. Participants are encouraged to go to the website 15 minutes prior to the start of the webcast to register, download and install any necessary software. Please note the below website will not be operational until approximately 60 minutes prior to the start of the webcast, which can be accessed via the following link:<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wFm52gOjsQrgtKIQ2A-OZMnU-r2IQuBXqQNrdVfsSaO300BazUiG0rYk2p9e10AM3dzJKPCWCuRZFqUOqgqq7JZe3gCs2uX0C_6xfa0F1YjtqPWYVkRkLNmNBJlXZjy-9UgFRWCr4gRcmBIqfjyyCd1XC5o4KhR1r1Sf3sdrE0LWwQVlIF9Fd9x1Rzu6BBSwUBbKSRMXc2nXW6S3NNF2HmOoIdUoFu53gLQBsJHCejDezmczcBvQFrZ1PuCZwqTP-vAaivw9bYUbYP0rrn8q6A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/78449.themediaframe.com\/dataconf\/productusers\/cydy\/mediaframe\/44014\/indexl.html<\/a>\n      <\/p>\n<p>The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until April 8, 2021.<\/p>\n<p>\n        <strong>CONTACTS<\/strong><br \/>\n        <br \/>\n        <strong>Investors: <\/strong><br \/>\n        <br \/>Michael Mulholland<br \/>Office: 360.980.8524, ext. 102<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mDN22lEZLWZerEbATctZLPs1cqICIGYvTjVSE8fVDsyegDDdBDOC8-IleuJgh60qV3rfVNUJO3AesG4CMTNhHMnh-wlv6vgJGmOlMz4ha4k=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mmulholland@cytodyn.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/16933cb3-d99e-444f-a902-466d35a96ac0\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, Washington, March 05, 2021 (GLOBE NEWSWIRE) &#8212; CytoDyn Inc. (OTC.QB: CYDY), (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman and Chief Medical Officer, Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer and Harish Seethamraju, M.D., Medical Director for the Mount Sinai Lung Transplantation Program, will host an investment community webcast on Monday, March 8, 2021. Management will discuss the data from the recently completed Phase 3 trial for severe-to-critically ill COVID-19 patients, the regulatory path forward with several countries, as well as updates on other clinical and corporate priorities. Management will provide &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-452089","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, Washington, March 05, 2021 (GLOBE NEWSWIRE) &#8212; CytoDyn Inc. (OTC.QB: CYDY), (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman and Chief Medical Officer, Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer and Harish Seethamraju, M.D., Medical Director for the Mount Sinai Lung Transplantation Program, will host an investment community webcast on Monday, March 8, 2021. Management will discuss the data from the recently completed Phase 3 trial for severe-to-critically ill COVID-19 patients, the regulatory path forward with several countries, as well as updates on other clinical and corporate priorities. Management will provide &hellip; Continue reading &quot;CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-05T23:33:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil\",\"datePublished\":\"2021-03-05T23:33:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/\"},\"wordCount\":317,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/\",\"name\":\"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=\",\"datePublished\":\"2021-03-05T23:33:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/","og_locale":"en_US","og_type":"article","og_title":"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil - Market Newsdesk","og_description":"VANCOUVER, Washington, March 05, 2021 (GLOBE NEWSWIRE) &#8212; CytoDyn Inc. (OTC.QB: CYDY), (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman and Chief Medical Officer, Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer and Harish Seethamraju, M.D., Medical Director for the Mount Sinai Lung Transplantation Program, will host an investment community webcast on Monday, March 8, 2021. Management will discuss the data from the recently completed Phase 3 trial for severe-to-critically ill COVID-19 patients, the regulatory path forward with several countries, as well as updates on other clinical and corporate priorities. Management will provide &hellip; Continue reading \"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-05T23:33:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil","datePublished":"2021-03-05T23:33:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/"},"wordCount":317,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/","name":"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=","datePublished":"2021-03-05T23:33:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NTQ5NiM0MDUxMjg1IzIwMjY1OTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-march-8-to-provide-overview-of-cd12-trial-data-and-regulatory-path-forward-with-the-u-s-u-k-canada-philippines-and-brazil\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452089","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=452089"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/452089\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=452089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=452089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=452089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}